Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer

Background: Chemotherapy for non-small-cell lung cancer (NSCLC) still leads to unsatisfactory clinical prognosis because of poor active targeting and tumor metastasis. Purpose: The objective of this study was to construct a kind of PFV peptide modified targeted daunorubicin and dioscin codelivery li...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanyuan, Fu, Min, Liu, Jingjing, Yang, Yining, Yu, Yibin, Li, Jinyu, Pan, Weisan, Fan, Lei, Li, Guiru, Li, Xuetao, Wang, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551515/
https://www.ncbi.nlm.nih.gov/pubmed/31239668
http://dx.doi.org/10.2147/IJN.S194304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551515/
https://www.ncbi.nlm.nih.gov/pubmed/31239668
http://dx.doi.org/10.2147/IJN.S194304

Ejemplares similares